-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tiratricol in Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tiratricol in Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tiratricol in Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tiratricol in Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tiratricol in Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Tiratricol in Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency)Drug Details:Tiratricol is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Birociclib in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Birociclib in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Birociclib in Human...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPN-2853 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPN-2853 in Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPN-2853 in Ovarian Cancer Drug Details: PLX-2853 is under development for the...
-
Product Insights
Liver Failure (Hepatic Insufficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Liver failure is severe deterioration of liver function. Liver failure occurs when a large portion of the liver is damaged due to any type of liver disorder. Symptoms may include jaundice, a tendency to bruise or bleed easily, ascites, impaired brain function (encephalopathy), poor weight gain and growth, fatigue, weakness, nausea, and loss of appetite. Since these symptoms are associated with a host of other conditions, it may take some time before the correct diagnosis is made. As liver failure...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – tiratricol
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry tiratricol Drug Details Tiratricol is under development for the treatment of monocarboxylate 8 transporter...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PP-100
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry PP-100 Drug Details PP-100 is under development for the treatment of acute liver failure...
-
Product Insights
Drug Overdose Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Drug Overdose can occur with multiple symptoms including sleepiness, confusion, chest pain, seizures, abdominal pain, nausea, vomiting, and diarrhea. Treatment includes antidote and activated charcoal. The Drug Overdose pipeline market report provides a comprehensive overview of the therapeutics under development for Drug Overdose, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history,...
-
Product Insights
Chemotherapy Induced Peripheral Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Chemotherapy-induced Peripheral Neuropathy - Drugs in Development research report provides a comprehensive overview on the therapeutics under development for Chemotherapy-induced Peripheral Neuropathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for...